Skip to main content

Table 1 Baseline characteristics of patients with and without coronary artery disease

From: Elevated serum interleukin-6 is predictive of coronary artery disease in intermediate risk overweight patients referred for coronary angiography

Characteristics

NCAD (N = 13)

CAD (N = 35)

p

Male sex n (%)

4 (30.7)

17 (48.5)

0.298

Age (years)

59.6 ± 6.0

56.9 ± 7.5

0.240

BMI

24.52 ± 4.93

27.92 ± 4.64

0.037

BMI >25 (%)

4 (30.7)

28 (82.3)

0.001

Smoking (%)

6 (46.1)

8 (22.8)

0.136

Abdominal circumference (cm)

88.23 ± 11.78

95.59 ± 8.71

0.059

Presence of hypertension (%)

7 (53.8)

9 (25.7)

0.254

Metabolic syndrome n (%)

3 (23.0)

15 (44.1)

0.186

ASCVD risk score (mean ± SD)

10.58 ± 7.62

9.72 ± 6.54

0.706

Previous AMI n (%)

1 (7.69)

5 (14.2)

0.547

Systolic blood pressure (mmHg)

134.94 ± 16.60

138.87 ± 22.52

0.571

Diastolic blood pressure (mmHg)

73.08 ± 16.53

80.80 ± 11.69

0.084

Serum creatinine (mg/dL)

0.68 ± 0.12

0.81 ± 0.22

0.057

UAlb/Ucre (mg/g)

13.5 ± 24.5

24.9 ± 39.8

0.165

Fasting plasma glucose (mg/dL)

93.31 ± 10.59

92.82 ± 8.80

0.878

HbA1c (%)

5.60 ± 0.37

5.68 ± 0.33

0.493

Fasting insulin (µU/mL)

9.21 ± 4.20

12.04 ± 6.64

0.139

HOMA-IR

2.18 ± 1.16

2.84 ± 1.65

0.250

Total cholesterol (mg/dL)

173.21 ± 63.13

179.97 ± 39.19

0.664

HDLc (mg/dL)

49.62 ± 11.4

43.39 ± 10.6

0.097

Triglycerides (mg/dL)

107.15 ± 56.64

132.79 ± 82.84

0.318

hs-CRP (mg/L)

4.59 ± 5.74

5.74 ± 6.01

0.565

Alanina transferase (ALT) (mg/dL)

19.15 ± 3.80

24.82 ± 26.54

0.455

On ASA n (%)

6 (46.1)

22 (70.9)

0.198

On statin n (%)

7 (53.8)

24 (77.4)

0.096

  1. NCAD patients without coronary artery disease. CAD patients with coronary artery disease. UAlb/Ucre was the ratio between urinary albumin concentration and urinary creatinine concentrations. Data are expressed as mean ± SD for all continuous and parametric variables. UAlb/Ucre (mg/g) data were expressed as median and 95% confidence interval
  2. BMI body mass index (Kg/cm2), ASCVD atherosclerotic cardiovascular disease, AMI acute myocardial infarction, HbA1c glycated hemoglobin, HOMA-IR homeostasis model assessment resistance, HDL c high density lipoprotein cholesterol (mg/dL), GPT alanine aminotransferase, ASA acetyl salicilic acid, Ins insulin, HbA1c glycated haemoglobin, hs-CRP high-sensitive C-reactive protein (mg/L)